Immunology of bronchial carcinoma.
D000818:Animals; D000942:Antigens, Bacterial / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D001500:BCG Vaccine / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000150:complications / Q000276:immunology* / Q000628:therapy; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002471:Cell Transformation, Neoplastic; D003601:Cytotoxicity Tests, Immunologic; D006168:Guinea Pigs; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D037102:Lectins / Q000494:pharmacology; D007978:Levamisole / Q000627:therapeutic use; D008213:Lymphocyte Activation; D008264:Macrophages; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D009360:Neoplastic Cells, Circulating; D009404:Nephrotic Syndrome / Q000150:complications; D011817:Rabbits; D051381:Rats
D000942:Antigens, Bacterial; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen; D037102:Lectins; D007978:Levamisole